CRBP earnings: a negative outcome, -12.4%

On May 9, 2023, Corbus Pharmaceuticals Holdings, Inc. reached its earnings. The result was a negative outcome, and the stock moved -12.4% in the window around the event. It had already run +35.6% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.